April 28, 2022

Abata Therapeutics Appoints Sandy Lazzari as Chief People Officer

Abata in the News

Abata Announces Formation of Advisory Board Comprised of Leading Industry Experts in Treg Biology, Cell Therapy and Corporate Development

Press Release
April 6, 2022

Does It Matter Where You Locate Your Biopharma Anymore?

Life Science Leader
December 3, 2021

Treg engineers take aim at autoimmunity

Nature Biotechnology
November 9, 2021

Abata Therapeutics Strengthens Board of Directors

Press Release
July 28, 2021

A Potential Transformational Therapy for Progressive MS

RealTalk MS
July 21, 2021

Cell therapy startup Abata launches with $95 million in funding

C&EN
June 23, 2021

How Abata new strategy in non-relapsing MS? Third Rock leads $95M series A

BioWorld
June 23, 2021

Abata: engineering targeted Treg cell therapies with TCRs

BioCentury
June 23, 2021

Abata hopes to find ‘perfect fit’ with MS cell therapy after $95M series A

Fierce Biotech
June 23, 2021

Third Rock seeds cell therapy startup with $95M in bid to cure MS

Endpoints News
June 23, 2021